UBS See More Downside in Edwards Lifesciences (EW), PT Lowered to $64
Tweet Send to a Friend
UBS today maintained a Sell rating on Edwards Lifesciences (NYSE: EW) and lowered its price target to $64.00 (from $82) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
